Skip to content

Additional dose of hepatitis B vaccine improves response in patients with HIV

New hepatitis C drugs pose many questions

Treatment breaks lead to fibrosis in HIV/HCV-co-infected patients

Atazanavir safe and effective for HIV/HCV patients with cirrhosis

We’re getting there: towards a comprehensive hepatitis C cure

Entecavir and Truvada an option for HBV for treatment-experienced HIV/HBV-co-infected patients

Accelerated HBV vaccination schedule an option for HIV patients if CD4 cell count is high

Good survival rates for HIV/HCV-coinfected patients with compensated cirrhosis

High rate of HCV reinfection after treatment of acute infection in Amsterdam gay men